The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
about
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationA Review of Nebivolol Pharmacology and Clinical EvidenceA comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients.Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension.Nebivolol: impact on cardiac and endothelial function and clinical utility.The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertensionEffect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertensionDifferential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.Nebivolol for heart failure in the elderly.Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aortaNitric oxide mechanisms of nebivolol.Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome.Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action.The Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery.Different effects of atenolol and nebivolol on coronary flow reserve.Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries.Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.Effects of nebivolol on left ventricular function in elderly patients with chronic heart failure: results of the ENECA study.Early effects of treatment with nebivolol and quinapril on endothelial function in patients with hypertension.
P2860
Q24681317-31CD083B-B82E-4186-A1B8-2B2979315571Q26801287-E8BA67B8-3FA3-41B8-B240-68E13C806D4CQ34349839-FFEFF49E-9CC1-4D88-AE9D-FFF031DABE17Q34506047-386F809E-9F43-42CE-BBCC-2F1E3F16D189Q34609451-8360625F-16CA-4215-A193-8009C901BDD1Q35157112-49E9FD25-8663-4BC9-AC94-9B756DEAF53BQ35846698-B61A6FC1-A6CB-44D5-A9A4-8BB469CB3A25Q36025103-8E1DD157-8650-4937-B26B-815E5D93E0D6Q36072467-852EED78-299B-4963-96C7-C99901232173Q36109889-9F81AD1B-6F0E-439E-8923-7D1F707AAAD7Q36596852-C2993458-8928-4236-8178-15A4D76108DDQ36815960-4D7FD657-CCBA-458C-9D21-613F58CC4373Q37033656-8F9C193E-3CF5-4AA2-93AF-CD52B889E777Q37230717-29B7BC0A-BAD3-41B3-B326-969D3929C284Q37483065-DE676DF6-129D-403B-AA46-1C5E15CEBF82Q38544207-2E4F78EA-3980-4B1D-8097-70D6B920BF44Q39370913-1C30B65F-61AC-4C37-98B2-4670FC9DEDBAQ40128025-98A0B974-24F3-4663-A06C-B420F8D794DDQ42105972-CBE8705B-DCE9-407F-A3F3-1FD629D31B73Q42733139-CBE82EAA-0F74-4DA7-A99D-184F0B106490Q43244752-AEACA542-7C0C-4B4E-B5CA-16970386B076Q43690830-220F9075-7C68-4541-BA07-1B6B1EF89CB8Q44375078-55B6E024-9EBE-44E9-B2ED-B7BF0864F564Q46514966-9C2DDE8B-2837-41B3-9311-7E5D947C2B11Q46527884-35E9DA42-8B6E-44D9-A5EE-A8741A37FAE8
P2860
The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
The vasodilator action of nebi ...... s with essential hypertension.
@ast
The vasodilator action of nebi ...... s with essential hypertension.
@en
type
label
The vasodilator action of nebi ...... s with essential hypertension.
@ast
The vasodilator action of nebi ...... s with essential hypertension.
@en
prefLabel
The vasodilator action of nebi ...... s with essential hypertension.
@ast
The vasodilator action of nebi ...... s with essential hypertension.
@en
P2093
P2860
P1476
The vasodilator action of nebi ...... s with essential hypertension.
@en
P2093
J M Ritter
P J Chowienczyk
P2860
P304
P356
10.1046/J.1365-2125.1999.00037.X
P407
P577
1999-09-01T00:00:00Z